Literature DB >> 29289484

What do we know about the diagnostics, treatment and epidemiology of Clostridioides (Clostridium) difficile infection in Europe?

Elisabeth Nagy1.   

Abstract

Clostridium difficile, recently reclassified as Clostridioides difficile is responsible for a significant part of diarrheal diseases in the hospitals and in the community. Besides the main pathogenic factors, toxin A, toxin B and the binary toxin, several other putative virulence factors have been investigated. This manuscript summarize recent findings in Europe concerning source of infection, epidemiology of CDI, the changing pattern of PCR ribotypes of C. difficile strains in different European countries, recommendations for diagnosis and treatment of CDI.
Copyright © 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridioides difficile; Diagnostics; Epidemiology; European perspective; Pathogenesis; Therapy

Mesh：

Year:  2017        PMID： 29289484     DOI： 10.1016/j.jiac.2017.12.003

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN： 1341-321X            Impact factor:   2.211


  10 in total

Review 1.  Sporulation and Germination in Clostridial Pathogens.

Authors:  Aimee Shen; Adrianne N Edwards; Mahfuzur R Sarker; Daniel Paredes-Sabja
Journal:  Microbiol Spectr       Date:  2019-11

2.  Mild or Malign: Clinical Characteristics and Outcomes of Clostridium difficile Infection in Thailand.

Authors:  Korakrit Imwattana; Papanin Putsathit; Teera Leepattarakit; Pattarachai Kiratisin; Thomas V Riley
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

Review 3.  An Overview of Healthcare Associated Infections and Their Detection Methods Caused by Pathogen Bacteria in Romania and Europe.

Authors:  Sándor Szabó; Bogdan Feier; Denisa Capatina; Mihaela Tertis; Cecilia Cristea; Adina Popa
Journal:  J Clin Med       Date:  2022-06-04       Impact factor: 4.964

4.  Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain.

Authors:  Miguel Salavert; Javier Cobo; Álvaro Pascual; Belén Aragón; Stefano Maratia; Yiling Jiang; Susana Aceituno; Santiago Grau
Journal:  Adv Ther       Date:  2018-10-16       Impact factor: 3.845

5.  Clostridium difficile toxins or infection induce upregulation of adenosine receptors and IL-6 with early pro-inflammatory and late anti-inflammatory pattern.

Authors:  D A Foschetti; M B Braga-Neto; D Bolick; J Moore; L A Alves; C S Martins; L E Bomfin; Aaqa Santos; Rfc Leitão; Gac Brito; C A Warren
Journal:  Braz J Med Biol Res       Date:  2020-07-24       Impact factor: 2.590

6.  Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017.

Authors:  Korakrit Imwattana; Papanin Putsathit; Deirdre A Collins; Teera Leepattarakit; Pattarachai Kiratisin; Thomas V Riley; Daniel R Knight
Journal:  Microb Genom       Date:  2022-03

Review 7.  Clostridioides difficile Infection in Patients after Organ Transplantation-A Narrative Overview.

Authors:  Sylwia Dudzicz-Gojowy; Andrzej Więcek; Marcin Adamczak
Journal:  J Clin Med       Date:  2022-07-27       Impact factor: 4.964

Review 8.  Gut Microbiota Composition Associated with Clostridioides difficile Colonization and Infection.

Authors:  Elisa Martinez; Bernard Taminiau; Cristina Rodriguez; Georges Daube
Journal:  Pathogens       Date:  2022-07-08

9.  Lactobacillus plantarum 299v Reduces the Incidence of Clostridium difficile Infection in Nephrology and Transplantation Ward-Results of One Year Extended Study.

Authors:  Sylwia Dudzicz; Agata Kujawa-Szewieczek; Katarzyna Kwiecień; Andrzej Więcek; Marcin Adamczak
Journal:  Nutrients       Date:  2018-10-24       Impact factor: 5.717

10.  Correlation between antibiotic consumption and the incidence of healthcare facility-onset Clostridioides difficile infection: a retrospective chart review and analysis.

Authors:  Ji Hyun Yun; Ga Eun Park; Hyun Kyun Ki
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-06       Impact factor: 4.887
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.